DETECÇÃO DE MARCADORES DE RESISTÊNCIA A MÚLTIPLAS DROGAS NA PELE DE CÃES COM INFECÇÃO NATURAL por Leishmania (Leishmania) infantum chagasi (CUNHA E CHAGAS, 1937) SHAW, 2002, SUBMETIDOS A DIFERENTES PROTOCOLOS DE TRATAMENTO

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  2014-07-02

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• LEISHMANIOSE VISCERAL CANINA: REVISÃO DE LITERATURA

  2018cited by this paper
• Expressão da glicoproteína-P, proteína associada à múltiplas drogas, glutationa-S-transferase pi e p53 no tumor venéreo transmissível canino

  2014cited by this paper
• Characterization of ABC transporters in human skin

  2014cited by this paper
• Experimental model for reproduction of canine visceral leishmaniosis by Leishmania infantum.

  2013cited by this paper
• Species-specific properties and translational aspects of canine dendritic cells.

  2013cited by this paper
• Asymptomatic dogs are highly competent to transmit Leishmania (Leishmania) infantum chagasi to the natural vector.

  2013cited by this paper
• Treatment of canine leishmaniosis with aminosidine at an optimized dosage regimen: a pilot open clinical trial.

  2013cited by this paper
• Canine visceral leishmaniasis: diagnostic approaches based on polymerase chain reaction employing different biological samples.

  2013cited by this paper
• POSITIVIDADE PARA LEISHMANIOSE VISCERAL CANINA: EXISTEM FATORES CANINOS QUE CONTRIBUEM?

  2013cited by this paper
• A systematic review and meta-analysis of the factors associated with Leishmania infantum infection in dogs in Brazil.

  2013cited by this paper
• Control of visceral leishmaniasis in Brazil: recommendations from Brasileish

  2013cited by this paper
• In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.

  2013cited by this paper
• Diagnosis of canine visceral leishmaniasis: major technological advances and few practical applications Diagnóstico de la Leishmaniasis Visceral Canina: grandes avances

  2013cited by this paper
• Adverse drug reactions in veterinary patients associated with drug transporters.

  2013cited by this paper
• Canine leishmaniosis in the Old and New Worlds: unveiled similarities and differences.

  2012cited by this paper
• Canine leishmaniosis. Modulation of macrophage/lymphocyte interactions by L. infantum.

  2012cited by this paper
• Evaluation of a novel chromatographic immunoassay based on Dual-Path Platform technology (DPP® CVL rapid test) for the serodiagnosis of canine visceral leishmaniasis.

  2012cited by this paper
• Risk factors for canine leishmaniasis in an endemic Mediterranean region.

  2012cited by this paper
• Monitoring the reverse to normal of clinico-pathological findings and the disease free interval time using four different treatment protocols for canine leishmaniosis in an endemic area.

  2012cited by this paper
• Clinical and laboratory alterations in dogs naturally infected by Leishmania chagasi.

  2012cited by this paper
• Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein.

  2012cited by this paper
• [Leishmaniasis diagnosis: going from microscopic observation of parasite to DNA detection].

  2012cited by this paper
• P‐Glycoprotein (ABCB1) expression in human skin is mainly restricted to dermal components

  2011cited by this paper
• Detection of Leishmania (L.) chagasi in canine skin.

  2011cited by this paper
• P-glycoprotein Substrate Models Using Support Vector Machines Based on a Comprehensive Data set

  2011cited by this paper
• LeishVet guidelines for the practical management of canine leishmaniosis

  2011cited by this paper
• How effective is dog culling in controlling zoonotic visceral leishmaniasis? A critical evaluation of the science, politics and ethics behind this public health policy.

  2011cited by this paper
• Transplacental Transmission of Leishmania infantum as a Means for Continued Disease Incidence in North America

  2011cited by this paper
• Guidelines for treatment of leishmaniasis in dogs.

  2010cited by this paper
• Expressão da glicoproteína-p e da mrp1 em tecidos de cães portadores de leishmaniose visceral

  2010cited by this paper
• Detection of Leishmania infantum in Rhipicephalus sanguineus ticks from Brazil and Italy

  2010cited by this paper
• Canine leishmaniasis. Immunophenotypic profile of leukocytes in different compartments of symptomatic, asymptomatic and treated dogs.

  2010cited by this paper
• Spontaneous canine transmissible venereal tumor: cell morphology and influence on P-glycoprotein expression

  2010cited by this paper
• Venereal transmission of canine visceral leishmaniasis.

  2009cited by this paper
• Redox Regulation of Multidrug Resistance in Cancer Chemotherapy: Molecular Mechanisms and Therapeutic Opportunities

  2009cited by this paper
• Células T regulatórias: mecanismos de ação e função nas doenças humanas

  2009cited by this paper
• Systemic and compartmentalized immune response in canine visceral leishmaniasis.

  2009cited by this paper
• Exames parasitológicos, imunoistoquímicos e histopatológicos para detecção de Leishmania chagasi em tecidos esplênicos de cães com leishmaniose visceral Parasitological, immunohistochemical and histopathological study for Leishmania chagasi detection in spleenic tissues of dogs with visceral leishma

  2009cited by this paper
• Expression of ABC-transport proteins in canine mammary cancer: consequences for chemotherapy.

  2009cited by this paper
• Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.

  2009cited by this paper
• Potential role for dog fleas in the cycle of Leishmania spp.

  2009cited by this paper
• Use of domperidone in the treatment of canine visceral leishmaniasis: a clinical trial.

  2009cited by this paper
• Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one.

  2008cited by this paper
• P-glycoprotein (Abcb1) is involved in absorptive drug transport in skin.

  2008cited by this paper
• Detection of natural infection in Lutzomyia cruzi and Lutzomyia forattinii (Diptera: Psychodidae: Phlebotominae) by Leishmania infantum chagasi in an endemic area of visceral leishmaniasis in Brazil using a PCR multiplex assay.

  2008cited by this paper
• Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1)

  2007cited by this paper
• Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune® vaccine

  2007cited by this paper
• Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi.

  2007cited by this paper
• Evaluation of transformation growth factor beta1, interleukin-10, and interferon-gamma in male symptomatic and asymptomatic dogs naturally infected by Leishmania (Leishmania) chagasi.

  2007cited by this paper
• Peripheral blood mononuclear cell supernatants from asymptomatic dogs immunized and experimentally challenged with Leishmania chagasi can stimulate canine macrophages to reduce infection in vitro.

  2007cited by this paper
• Adverse Drug Reactions in Herding-Breed Dogs: The Role of P-Glycoprotein *

  2006cited by this paper
• Leishmania infantum released proteins specifically regulate cytokine expression and production patterns by CD4+ and CD8+ T cells.

  2006cited by this paper
• Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies?

  2006cited by this paper
• Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis.

  2006cited by this paper
• Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control.

  2006cited by this paper
• Multi-drug resistance (MDR1) gene and P-glycoprotein influence on pharmacokinetic and pharmacodymanic of therapeutic drugs

  2006cited by this paper
• Immunology of canine leishmaniasis

  2006cited by this paper
• Substrate recognition and transport by multidrug resistance protein 1 (ABCC1)

  2006cited by this paper
• CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells.

  2006cited by this paper
• Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system.

  2006cited by this paper
• Further thoughts on the use of the name Leishmania (Leishmania) infantum chagasi for the aetiological agent of American visceral leishmaniasis.

  2006cited by this paper
• Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells

  2005cited by this paper
• Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.

  2005cited by this paper
• Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.

  2005cited by this paper
• Multidrug Resistance—Associated Protein 1 Functions as an Efflux Pump of Xenobiotics in the Skin

  2005cited by this paper
• Macrophage and Leishmania: An Unacceptable Coexistence

  2005cited by this paper
• Lutzomyia longipalpis and the eco-epidemiology of American visceral leishmaniasis, with particular reference to Brazil: a review.

  2005cited by this paper
• An alternative immunohistochemical method for detecting Leishmania amastigotes in paraffin-embedded canine tissues.

  2004cited by this paper
• Multidrug Resistance Protein (MRP) 4- and MRP 5-Mediated Efflux of 9-(2-Phosphonylmethoxyethyl)adenine by Microglia

  2004cited by this paper
• Dynamics of CD62L/CD45RB CD4+ and CD8+ lymphocyte subsets in hepatic and splenic tissues during murine visceral leishmaniasis.

  2004cited by this paper
• Quantification of MDR-1 gene expression in canine tissues by real-time reverse transcription quantitative polymerase chain reaction.

  2004cited by this paper
• Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines.

  2003cited by this paper
• Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

  2003cited by this paper
• Molecular diagnosis of leishmaniasis

  2003cited by this paper
• Dexamethasone treatment of a canine, but not human, tumour cell line increases chemoresistance independent of P-glycoprotein and multidrug resistance-related protein expression.

  2003cited by this paper
• Activation of TGF-β by Leishmania chagasi: Importance for Parasite Survival in Macrophages 1

  2003cited by this paper
• DRUG RESISTANCE PATHWAYS AS TARGETS

  2002cited by this paper
• CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

  2002cited by this paper
• MDR1 genotype-related pharmacokinetics and pharmacodynamics.

  2002cited by this paper
• Chemotherapy of canine leishmaniosis.

  2002cited by this paper
• Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1.

  2001cited by this paper
• Tissue cytokine responses in canine visceral leishmaniasis.

  2001cited by this paper
• The leishmaniases as emerging and reemerging zoonoses.

  2000cited by this paper
• Genomic diversity in the Leishmania donovani complex

  1999cited by this paper
• A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels.

  1998cited by this paper
• Co-stimulation in T cell responses.

  1997cited by this paper
• Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.

  1996cited by this paper
• Immunohistochemical Detection of P-glycoprotein in Formalin-fixed and Paraffin-embedded Normal and Neoplastic Canine Tissues

  1996cited by this paper
• The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates.

  1994cited by this paper
• A canine CD8+ cytotoxic T-cell line specific for Leishmania infantum-infected macrophages.

  1994cited by this paper
• Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.

  1994cited by this paper
• Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum

  1994cited by this paper
• Short communication Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells

  1993cited by this paper
• P-glycoprotein (MDR 1 gene product) in cells of the immune system: Its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection

  1993cited by this paper
• Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

  1992cited by this paper
• P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells.

  1992cited by this paper
• Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8 + T cells: A role in cytotoxic effector function

  1992cited by this paper
• Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells.

  1991cited by this paper
• Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania

  1989cited by this paper
• Functional heterogeneity of CD4+ T cells in leishmaniasis.

  1989cited by this paper

• No citing papers are available for this paper.